Guo-yue F. Lv - Publications

Post-transplant MASLD: a risk-stratified approach to assessment and personalized management.

Journal: Frontiers in medicine

Published: May 11, 2026

Safety and efficacy of liver transplantation for hepatocellular carcinoma with bile duct tumor thrombus: A single-arm, multicenter, prospective study.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: June 16, 2025

Exploring primate immune responses to SLA-I/II knockdown pig xenografts in humanized mice and rhesus monkeys.

Journal: Science China. Life sciences

Published: April 07, 2025

The Efficacy and Safety of Intrapancreatic Bile Duct Resection Applied in Type I of Congenital Bile Duct Dilation: A Multicenter Control Cohort Study.

Journal: Annals of surgery

Published: February 20, 2025

Cisplatin-induced disruption of mitochondrial divisome leads to enhanced cisplatin resistance in cholangiocarcinoma.

Journal: Journal of hepatology

Published: February 09, 2025

Stratifying risk of failure to achieve textbook outcomes among patients undergoing hepatectomy for hepatocellular carcinoma: A multicenter score validation study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 26, 2024

Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities.

Journal: Cancer science

Published: January 10, 2024

Preoperative frailty as a key predictor of short- and long-term outcomes among octogenarians undergoing hepatectomy for hepatocellular carcinoma: a multicenter comprehensive analysis.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: December 27, 2023

Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma.

Journal: iLIVER

Published: December 10, 2023

Development and validation of nomograms to predict survival and recurrence after hepatectomy for intermediate/advanced (BCLC stage B/C) hepatocellular carcinoma.

Journal: Surgery

Published: November 20, 2023

Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.

Journal: Frontiers in endocrinology

Published: October 22, 2023

Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis.

Journal: Frontiers in immunology

Published: October 16, 2023